Levothyroxine Sodium Tablets, USP 112 mcg (0.112mg), 1000 tablets, Rx Only, Manufactured for: Mac...

FDA Recall #D-0470-2025 — Class III — May 29, 2025

Recall #D-0470-2025 Date: May 29, 2025 Classification: Class III Status: Ongoing

Product Description

Levothyroxine Sodium Tablets, USP 112 mcg (0.112mg), 1000 tablets, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540. Manufactured by: Macleods Pharmaceuticals Ltd. Sarigam, Valsad, Gujarat, India, NDC 33342-398-44.

Reason for Recall

Presence of a foreign substance: black hair found embedded in tablet.

Recalling Firm

Macleods Pharmaceuticals Ltd — Mumbai

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

1,344- 1000 count bottles

Distribution

Nationwide in the USA

Code Information

Lot #: MLF2401A, Exp 01/31/2026

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated